CC
Callan Capital’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $292K | Buy |
2,131
+56
| +3% | +$7.66K | 0.02% | 290 |
|
|
2024
Q4 | $317K | Buy |
2,075
+970
| +88% | +$148K | 0.02% | 247 |
|
|
2024
Q3 | $214K | Sell |
1,105
-2,116
| -66% | -$410K | 0.02% | 321 |
|
|
2024
Q2 | $747K | Buy |
3,221
+180
| +6% | +$41.7K | 0.06% | 129 |
|
|
2024
Q1 | $656K | Buy |
3,041
+223
| +8% | +$48.1K | 0.06% | 124 |
|
|
2023
Q4 | $729K | Buy |
2,818
+329
| +13% | +$85.1K | 0.07% | 106 |
|
|
2023
Q3 | $640K | Sell |
2,489
-151
| -6% | -$38.8K | 0.07% | 100 |
|
|
2023
Q2 | $752K | Hold |
2,640
| – | – | 0.08% | 89 |
|
|
2023
Q1 | $734K | Hold |
2,640
| – | – | 0.09% | 89 |
|
|
2022
Q4 | $731K | Buy |
+2,640
| New | +$731K | 0.09% | 93 |
|
|
2016
Q3 | – | Sell |
-3,644
| Closed | -$881K | – | 50 |
|
|
2016
Q2 | $881K | Sell |
3,644
-552
| -13% | -$133K | 0.36% | 30 |
|
|
2016
Q1 | $1.09M | Hold |
4,196
| – | – | 0.46% | 26 |
|
|
2015
Q4 | $1.29M | Sell |
4,196
-330
| -7% | -$101K | 0.51% | 27 |
|
|
2015
Q3 | $1.32M | Hold |
4,526
| – | – | 0.72% | 24 |
|
|
2015
Q2 | $1.83M | Hold |
4,526
| – | – | 0.38% | 29 |
|
|
2015
Q1 | $1.91M | Hold |
4,526
| – | – | 0.41% | 29 |
|
|
2014
Q4 | $1.54M | Hold |
4,526
| – | – | 0.35% | 36 |
|
|
2014
Q3 | $1.5M | Sell |
4,526
-760
| -14% | -$251K | 0.41% | 34 |
|
|
2014
Q2 | $1.67M | Sell |
5,286
-130
| -2% | -$41K | 0.45% | 33 |
|
|
2014
Q1 | $1.66M | Hold |
5,416
| – | – | 0.55% | 26 |
|
|
2013
Q4 | $1.51M | Hold |
5,416
| – | – | 0.58% | 27 |
|
|
2013
Q3 | $1.3M | Buy |
5,416
+184
| +4% | +$44.3K | 0.62% | 26 |
|
|
2013
Q2 | $1.13M | Buy |
+5,232
| New | +$1.13M | 0.64% | 26 |
|